Schultz, Olaf <br/><br/>
Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases.  [electronic resource] 

 -  PloS one  Dec 2010 
 - e14328 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0014328  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipokines--blood<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Arthritis, Rheumatoid--metabolism<br/>Cytokines--metabolism<br/>Diabetes Mellitus, Type 2--metabolism<br/>Female<br/>Humans<br/>Insulin--metabolism<br/>Insulin Resistance<br/>Interleukin-6--metabolism<br/>Lipoprotein(a)--metabolism<br/>Male<br/>Middle Aged<br/>Signal Transduction